As of April 2024 Reata Pharmaceuticals has a market cap of $6.56 Billion. This makes Reata Pharmaceuticals the world's 2192th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $6.56 B | 0% |
2023 | $6.56 B | 371.7% |
2022 | $1.39 B | 45.06% |
2021 | $0.95 B | -78.51% |
2020 | $4.46 B | -34.21% |
2019 | $6.78 B | 306.91% |
2018 | $1.66 B | 125.51% |
2017 | $0.73 B | 51.67% |
2016 | $0.48 B |
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.59 B | -91.00% | ๐บ๐ธ USA |